B. Eriksson

发表

A new instrument for measuring self‐efficacy in patients with an anterior cruciate ligament injury

J. Karlsson, P. Thomeé, P. Währborg, 2006, Scandinavian journal of medicine & science in sports.

Early active extension after anterior cruciate ligament reconstruction does not result in increased laxity of the knee

J. Kärrholm, J. Karlsson, B. Eriksson, 2006, Knee Surgery, Sports Traumatology, Arthroscopy.

A new measurement of heel-rise endurance with the ability to detect functional deficits in patients with Achilles tendon rupture

J. Karlsson, R. Thomeé, B. Eriksson, 2010, Knee Surgery, Sports Traumatology, Arthroscopy.

Major functional deficits persist 2 years after acute Achilles tendon rupture

J. Karlsson, R. Thomeé, B. Eriksson, 2011, Knee Surgery, Sports Traumatology, Arthroscopy.

Ability to perform a single heel‐rise is significantly related to patient‐reported outcome after Achilles tendon rupture

J. Karlsson, B. Eriksson, K. Silbernagel, 2014, Scandinavian journal of medicine & science in sports.

Treatment of distal tibial fractures with the Ilizarov external fixator - a prospective observational study in 39 consecutive patients

J. Karlsson, B. Eriksson, T. Ramos, 2013, BMC Musculoskeletal Disorders.

Hand hygiene and aseptic techniques during routine anesthetic care - observations in the operating room

K. Nilsson, J. Karlsson, B. Eriksson, 2015, Antimicrobial Resistance and Infection Control.

The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.

M. Gent, B. Eriksson, A. Turpie, 2012, The Journal of bone and joint surgery. British volume.

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

B. Eriksson, A. Turpie, K. Bauer, 2002, Archives of internal medicine.

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients

D Bergqvist, B Eriksson, B. Eriksson, 2010, Journal of thrombosis and haemostasis : JTH.

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

S. Frostick, M. Prins, H. Büller, 2007, The Lancet.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

B. Eriksson, W. Geerts, M. Huisman, 2008, The New England journal of medicine.

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban — an Oral, Direct Factor Xa Inhibitor — in Patients Undergoing Major Orthopaedic Surgery

M. Gent, B. Eriksson, A. Turpie, 2008, Clinical pharmacokinetics.

KT-1000 records smaller side-to-side differences than radiostereometric analysis before and after an ACL reconstruction

J. Kärrholm, J. Karlsson, B. Eriksson, 2006, Knee Surgery, Sports Traumatology, Arthroscopy.

Factor V Leiden (G1691A) and Prothrombin Gene G20210A Mutations as Potential Risk Factors for Venous Thromboembolism after Total Hip or Total Knee Replacement Surgery

T. Lindahl, B. Eriksson, C. Andersson, 2002, Thrombosis and Haemostasis.

Kinematics after tear in the anterior cruciate ligament: Dynamic bilateral radiostereometric studies in 11 patients

J Kärrholm, J. Kärrholm, J. Karlsson, 2001, Acta orthopaedica Scandinavica.

High incidence of deep venous thrombosis after Achilles tendon rupture: a prospective study

J. Karlsson, B. Eriksson, K. Nilsson-Helander, 2009, Knee Surgery, Sports Traumatology, Arthroscopy.

Prevention of Venous Thromboembolism Following Orthopaedic Surgery

B. Eriksson, O. Dahl, 2012, Drugs.

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran.

B. Eriksson, G. Agnelli, D. Bergqvist, 2009, Thrombosis research.

Clinical Experience with Ximelagatran in Orthopaedic Surgery

B. Eriksson, 2004, Drugs.

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

B. Eriksson, L. Welin, L. Frison, 2002, The Lancet.

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

B. Eriksson, J. Weitz, D. Quinlan, 2009, Clinical pharmacokinetics.

Assessment of Bleeding after Concomitant Administration of Antiplatelet and Anticoagulant Agents in Lower Limb Arthroplasty

B. Eriksson, A. Cohen, G. Agnelli, 2006, Pathophysiology of Haemostasis and Thrombosis.

Subtalar Ankle Instability

P. Renström, J. Karlsson, B. Eriksson, 1997, Sports medicine.

Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty

B. Eriksson, J. Plumb, J. Caprini, 2008, Thrombosis and Haemostasis.

Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.

B. Eriksson, N. Rosencher, R. Friedman, 2012, Thrombosis research.

Ipsi- or Contralateral Patellar Tendon Graft in Anterior Cruciate Ligament Revision Surgery

J. Karlsson, B. Eriksson, J. Kartus, 1998, The American journal of sports medicine.

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement

B. Eriksson, A. Cohen, G. Agnelli, 2003, Thrombosis and Haemostasis.

Ilizarov external fixation or locked intramedullary nailing in diaphyseal tibial fractures: a randomized, prospective study of 58 consecutive patients

J. Karlsson, B. Eriksson, T. Ramos, 2014, Archives of Orthopaedic and Trauma Surgery.

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

H. Büller, B. Eriksson, N. Rosencher, 2005, Journal of thrombosis and haemostasis : JTH.

Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial

B. Eriksson, A. Shorr, A. Jaffer, 2012, Journal of thrombosis and haemostasis : JTH.

An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery.

B. Eriksson, M. Feuring, J. Amiral, 2016, Thrombosis research.

Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.

B. Eriksson, A. Turpie, K. Bauer, 2004, Chest.

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

B. Eriksson, M. Lassen, 2003, Archives of internal medicine.

Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study

B. Eriksson, H. Brisby, A. Jeppsson, 2015, Journal of Orthopaedic Surgery and Research.

Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty

M. Gent, B. Eriksson, A. Turpie, 2010, Thrombosis and Haemostasis.

Definition of major bleeding in surgery: an anesthesiologist’s point of view: reply to a rebuttal

B. Eriksson, D. Bergqvist, S. Schulman, 2010 .

Efficacy of delayed thromboprophylaxis with dabigatran: pooled analysis.

B. Eriksson, A. Clemens, S. Hantel, 2012, Thrombosis research.

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

B. Eriksson, G. Nehmiz, J. Stangier, 2004, Journal of thrombosis and haemostasis : JTH.

Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.

L. Signorello, B. Eriksson, L. Engstrand, 2000, Cancer research.

Bone mineral assessments in the calcaneus after anterior cruciate ligament injury An investigation of 92 male patients before and two years after reconstruction or revision surgery

J. Karlsson, U. Nilsson, B. Eriksson, 1998, Scandinavian journal of medicine & science in sports.

Factor V Leiden ( G 1691 A ) and Prothrombin Gene G 20210 A Mutations as Potential Risk Factors for Venous Thromboembolism after Total Hip or Total Knee Replacement Surgery

T. Lindahl, B. Eriksson, C. Andersson, 2018 .

New therapeutic options in deep vein thrombosis prophylaxis.

B. Eriksson, 2000, Seminars in hematology.

Optimization of ascending phlebography of the leg for screening of deep vein thrombosis in thromboprophylactic trials

B. Eriksson, P. Kälebo, B.-A. Anthmyr, 1997, Acta radiologica.

Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393

B. Eriksson, P. Close, P. Kälebo, 1996, The Lancet.

Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up study.

B. Eriksson, D. Bergqvist, L. Borris, 1996, The International journal of risk & safety in medicine.

A comparison of results in middle-aged and young patients after anterior cruciate ligament reconstruction.

J. Karlsson, B. Eriksson, J. Kartus, 2000, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance.

B. Eriksson, A. Greinacher, P. Eichler, 2003, Blood.

Clinical experience of melagatran/ximelagatran in major orthopaedic surgery.

B. Eriksson, 2003, Thrombosis research.

Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study

D. Ward, R. Rothlein, B. Eriksson, 2008, Journal of thrombosis and haemostasis : JTH.

Fondaparinux, the first selective factor Xa inhibitor

B. Eriksson, A. Turpie, K. Bauer, 2003, Current opinion in hematology.

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.

P. Wille-Jørgensen, B. Eriksson, P. Close, 1997, The New England journal of medicine.

Postoperative Melagatran/ Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery

B. Eriksson, A. Cohen, G. Agnelli, 2005, Clinical drug investigation.

Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism

B. Eriksson, A. Turpie, K. Bauer, 2002, Current opinion in pulmonary medicine.

Comparison of Two Anatomic Reconstructions for Chronic Lateral instability of the Ankle Joint

J. Karlsson, B. Eriksson, L. Swärd, 1997, The American journal of sports medicine.

Early functional treatment for acute ligament injuries of the ankle joint

J. Karlsson, B. Eriksson, L. Swärd, 1996, Scandinavian journal of medicine & science in sports.

A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement

B. Eriksson, M. Huisman, A. Kakkar, 2006, Circulation.

Antithrombotic Effect of Two Low Molecular Weight Thrombin Inhibitors and a Low-Molecular Weight Heparin in a Caval Vein Thrombosis Model in the Rat

B. Eriksson, B. Risberg, C. Mattsson, 1997, Thrombosis and Haemostasis.

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

M. Prins, B. Eriksson, A. Turpie, 2007, Journal of thrombosis and haemostasis : JTH.

Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.

B. Eriksson, I. Trocóniz, C. Tillmann, 2006, British journal of clinical pharmacology.

Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

B. Eriksson, M. Huisman, L. Borris, 2006, Journal of thrombosis and haemostasis : JTH.

Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.

C. Francis, B. Eriksson, J. Caprini, 2010, Thrombosis research.

Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies

M. Gent, B. Eriksson, A. Turpie, 2007, Thrombosis and Haemostasis.

YM150, an Oral Direct Factor Xa Inhibitor, as Prophylaxis for Venous Thromboembolism in Patients with Elective Primary Hip Replacement Surgery. A Dose Escalation Study.

M. Prins, B. Eriksson, A. Turpie, 2005 .

Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.

B. Eriksson, M. Huisman, A. Kakkar, 2007, Thrombosis research.

Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement

G. Raskob, B. Eriksson, J. Weitz, 2010, Thrombosis and Haemostasis.

Is a knee brace advantageous after anterior cruciate ligament surgery?

J. Karlsson, B. Eriksson, J. Kartus, 2001, Scandinavian journal of medicine & science in sports.

Regional fibrinolysis following total hip replacement.

B. Eriksson, E. Hultman, B. Risberg, 1991, Thrombosis research.

Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients.

B. Eriksson, B. Risberg, E. Eriksson, 1991, Thrombosis research.

Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery

J. Hirsh, J. Eikelboom, B. Eriksson, 2007, Journal of thrombosis and haemostasis : JTH.

A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery

G. Raskob, B. Eriksson, A. Turpie, 2010, Thrombosis and Haemostasis.

Continued Sports Activity, Using a Pain-Monitoring Model, during Rehabilitation in Patients with Achilles Tendinopathy

J. Karlsson, R. Thomeé, B. Eriksson, 2007, The American journal of sports medicine.

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)

M. Prins, B. Eriksson, A. Turpie, 2010, Journal of thrombosis and haemostasis : JTH.

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.

M. Gent, B. Eriksson, A. Turpie, 2009, The Journal of bone and joint surgery. British volume.

Percentage of Inadequate Phlebograms and Observer Agreement in Thromboprophylactic Multicenter Trials Using Standardized Methodology and Central Assessment

B. Eriksson, P. Close, P. Kälebo, 1996, Thrombosis and Haemostasis.

Prevention of Thromboembolism with Use of Recombinant Hirudin. Results of a Double-Blind, Multicenter Trial Comparing the Efficacy of Desirudin (Revasc) with That of Unfractionated Heparin in Patients Having a Total Hip Replacement*

B. Eriksson, P. Close, P. Kälebo, 1997, The Journal of bone and joint surgery. American volume.

Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study

B. Eriksson, A. Turpie, S. Schellong, 2007, Journal of thrombosis and haemostasis : JTH.

Thromboembolism in Orthopedic Surgery: Scope of the Problem

B. Eriksson, O. Dahl, 2013 .

Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: No increased risk of bleeding

B. Eriksson, J. Caprini, A. Clemens, 2012, Thrombosis and Haemostasis.

Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing or knee replacement

B. Eriksson, A. Clemens, N. Rosencher, 2012, International Orthopaedics.

New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.

B. Eriksson, A. Turpie, K. Bauer, 2003, Chest.

Is Colour Doppler Ultrasound a Sensitive Screening Method in Diagnosing Deep Vein Thrombosis after Hip Surgery ?

B. Eriksson, R. Sivertsson, P. Kälebo, 1996, Thrombosis and Haemostasis.

Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.

C. Colwell, S. Frostick, B. Eriksson, 2008, International angiology : a journal of the International Union of Angiology.

Dabigatran versus enoxaparin after total hip replacement – Authors' reply

B. Eriksson, S. Hantel, 2007, The Lancet.

Sex Differences in Outcome After an Acute Achilles Tendon Rupture

J. Karlsson, B. Eriksson, A. Brorsson, 2014, Orthopaedic journal of sports medicine.

Acute Achilles Tendon Rupture

J. Karlsson, R. Thomeé, B. Eriksson, 2010 .

A Randomized, Controlled Study Comparing Surgical and Nonsurgical Treatments Using Validated Outcome Measures

J. Karlsson, R. Thomeé, B. Eriksson, 2010 .

Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells.

K. Sjögren, C. Ohlsson, B. Eriksson, 1998, Biochemical and biophysical research communications.

Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.

B. Eriksson, D. Quinlan, 2013, Best practice & research. Clinical haematology.

Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery

B. Eriksson, A. Turpie, K. Bauer, 2003, The Lancet.

Central Assessment of Bilateral Phlebograms in a Major Multicentre Thromboprophylactic Trial

B. Eriksson, P. Kälebo, B. Zachrisson, 1999, Acta radiologica.

Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery.

B. Eriksson, D. Quinlan, 2006, Drugs.

A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.

B. Eriksson, A. Turpie, K. Bauer, 2002, Journal of the Southern Orthopaedic Association.

Fondaparinux.

B. Eriksson, A. Turpie, K. Bauer, 2020, The Journal of the American Academy of Orthopaedic Surgeons.

Thrombosis prophylaxis with low molecular weight heparin in total hip replacement

B. Eriksson, B. Risberg, A. Teger-Nilsson, 1988, The British journal of surgery.

Thrombosis after hip replacement. Relationship to the fibrinolytic system.

B. Eriksson, B. Risberg, E. Eriksson, 1989, Acta orthopaedica Scandinavica.

Phlebographic Findings in Venous Thrombosis following Total Hip Replacement

B. Eriksson, P. Kälebo, B.-A. Anthmyr, 1990, Acta radiologica.

Influence of the duration of fondaparinux (Arixtra®) prophylaxis in preventing venous thromboembolism following major orthopedic surgery

B. Eriksson, A. Turpie, K. Bauer, 2003, Journal of thrombosis and haemostasis : JTH.

Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients.

C. Colwell, B. Eriksson, M. Lassen, 2004, The Journal of arthroplasty.

A Comparative Study of Three Low-molecular Weight Heparins (LMWH) and Unfractionated Heparin (UH) in Healthy Volunteers

B. Eriksson, B. Risberg, L. Tengborn, 1995, Thrombosis and Haemostasis.

Complete mid-portion rupture of the rat achilles tendon leads to remote and time-mismatched changes in uninjured regions

B. Eriksson, F. S. da Silva, B. J. Abreu, 2020, Knee Surgery, Sports Traumatology, Arthroscopy.

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials

B. Eriksson, M. Feuring, A. Clemens, 2015, Thrombosis Journal.

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials

B. Eriksson, M. Feuring, A. Clemens, 2012, Thrombosis Journal.

Predictors of Clinical Outcome After Acute Achilles Tendon Ruptures

M. Petzold, J. Karlsson, B. Eriksson, 2014, The American journal of sports medicine.

Thromboprophylaxis after orthopaedic surgery with an oral, direct factor Xa inhibitor: Pooled results of two phase Iib clinical trials.

M. Gent, B. Eriksson, A. Turpie, 2005 .

Prevention of Venous Thromboembolism after Total Hip Replacement with Once-Daily BAY 59-7939 - An Oral, Direct Factor Xa Inhibitor.

B. Eriksson, M. Huisman, A. Kakkar, 2005 .

Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review

M. Gent, B. Eriksson, A. Turpie, 2004, Journal of thrombosis and haemostasis : JTH.

Fondaparinux Reduces Long-term Risk of Venous Thromboembolism After Surgery for Hip Fractur

C. Colwell, B. Eriksson, A. Turpie, 2003 .

Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

B. Eriksson, V. Marder, J. Kelton, 2005, Blood.

Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration

B. Eriksson, A. Turpie, K. Bauer, 2003, Thrombosis and Haemostasis.

A Dose-ranging Study of the Oral Direct Thrombin Inhibitor, Ximelagatran, and Its Subcutaneous Form, Melagatran, Compared with Dalteparin in the Prophylaxis of Thromboembolism after Hip or Knee Replacement: METHRO I

B. Eriksson, U. Eriksson, L. Frison, 2002, Thrombosis and Haemostasis.

Paper 19: Continued Sports Activity, Using a Pain-Monitoring Model, During Rehabilitation in Patients with Achilles Tendinopathy - A Randomized Controlled Study

J. Karlsson, R. Thomeé, B. Eriksson, 2012 .

Preoperative plasma fibrinogen concentration, factor XIII activity, perioperative bleeding, and transfusions in elective orthopaedic surgery: A prospective observational study.

B. Eriksson, H. Brisby, A. Jeppsson, 2016, Thrombosis research.

Detection of slow-cycling and stem/progenitor cells in different regions of rat Achilles tendon: response to treadmill exercise

J. Karlsson, B. Eriksson, H. Brisby, 2013, Knee Surgery, Sports Traumatology, Arthroscopy.

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

Bengt I Eriksson, B. Eriksson, A. Turpie, 2002, The Lancet.

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial

Bengt I Eriksson, B. Eriksson, A. Turpie, 2002, The Lancet.

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

B. Eriksson, A. Turpie, K. Bauer, 2001, The New England journal of medicine.

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

B. Eriksson, A. Turpie, K. Bauer, 2001, The New England journal of medicine.

Depression of peritoneal fibrinolysis during operation is a local response to trauma.

B. Eriksson, B. Risberg, E. Eriksson, 1998, Surgery.

Complications following arthroscopic anterior cruciate ligament reconstruction A 2–5-year follow-up of 604 patients with special emphasis on anterior knee pain

J. Karlsson, B. Eriksson, J. Kartus, 1999, Knee Surgery, Sports Traumatology, Arthroscopy.

A new surgical method to treat chronic ruptures and reruptures of the Achilles tendon

J. Karlsson, R. Thomeé, B. Eriksson, 2008, Knee Surgery, Sports Traumatology, Arthroscopy.

The Ilizarov external fixator - a useful alternative for the treatment of proximal tibial fractures A prospective observational study of 30 consecutive patients

J. Karlsson, B. Eriksson, C. Ekholm, 2013, BMC Musculoskeletal Disorders.

Population pharmacokinetics and pharmacodynamics of once and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement

Bengt I Eriksson, Sylvia Haas, B. Eriksson, 2008, Thrombosis and Haemostasis.

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

B. Eriksson, K. Rathgen, G. Nehmiz, 2005, Journal of clinical pharmacology.

The Achilles Tendon Total Rupture Score (ATRS)

Jon Karlsson, J. Karlsson, P. Thomeé, 2007, The American journal of sports medicine.

Traffic flow in the operating room: an explorative and descriptive study on air quality during orthopedic trauma implant surgery.

Annette Erichsen Andersson, Kerstin Nilsson, Ingrid Bergh, 2012, American journal of infection control.

Serial magnetic resonance imaging of the donor site after harvesting the central third of the patellar tendon A prospective study of 37 patients after arthroscopic anterior cruciate ligament reconstruction

J. Karlsson, B. Eriksson, J. Kartus, 1999, Knee Surgery, Sports Traumatology, Arthroscopy.

Factors affecting donor-site morbidity after anterior cruciate ligament reconstruction using bone-patellar tendon-bone autografts

J. Karlsson, B. Eriksson, J. Kartus, 1997, Knee Surgery, Sports Traumatology, Arthroscopy.

Magnetic resonance imaging of the patellar tendon after harvesting its central third: a comparison between traditional and subcutaneous harvesting techniques.

J. Karlsson, B. Eriksson, J. Kartus, 1999, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

Closing patellar tendon defects after anterior cruciate ligament reconstruction: absence of any benefit

J. Karlsson, B. Eriksson, O. Lundin, 1998, Knee Surgery, Sports Traumatology, Arthroscopy.

Comparison of arthroscopic one‐incision and two‐incision techniques for reconstruction of the anterior cruciate ligament

J. Karlsson, B. Eriksson, J. Kartus, 1999, Scandinavian journal of medicine & science in sports.

Short reports Reconstruction of the anterior cruciate ligament: comparison of outside-in and all-inside techniques

J. Karlsson, B. Eriksson, O. Lundin, 1999 .

Stable Surgical Repair With Accelerated Rehabilitation Versus Nonsurgical Treatment for Acute Achilles Tendon Ruptures

Nicklas Olsson, Bengt I Eriksson, J. Karlsson, 2013, The American journal of sports medicine.

Efficacy and Safety Profile of Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Moderately Renally Impaired Patients after Total Knee or Hip Replacement Surgery.

B. Eriksson, A. Clemens, N. Rosencher, 2008 .

Efficacy and Safety Profile of Dabigatran Etexilate Compared with Enoxaparin in Primary Venous Thromboembolism Prevention after Total Knee or Hip Replacement Surgery in Patients Over 75 Years

B. Eriksson, A. Clemens, N. Rosencher, 2008 .

Surgical treatment of concomitant chronic ankle instability and longitudinal rupture of the peroneus brevis tendon

J. Karlsson, B. Eriksson, S. Brandsson, 1998, Scandinavian journal of medicine & science in sports.

Biodegradable and Metallic Interference Screws in Anterior Cruciate Ligament Reconstruction Surgery Using Hamstring Tendon Grafts

Jon Karlsson, Bengt I Eriksson, J. Karlsson, 2006, The American journal of sports medicine.

Analysis of subjective, objective and functional examination tests after anterior cruciate ligament reconstruction A follow-up of 527 patients

J. Karlsson, B. Eriksson, J. Kartus, 1999, Knee Surgery, Sports Traumatology, Arthroscopy.

A prospective four‐ to seven‐year follow‐up after arthroscopic anterior cruciate ligament reconstruction

J. Karlsson, B. Eriksson, J. Kartus, 2001, Scandinavian journal of medicine & science in sports.

A comparison of results after arthroscopic anterior cruciate ligament reconstruction in female and male competitive athletes A two‐ to five‐year follow‐up of 429 patients

J. Karlsson, B. Eriksson, J. Kartus, 1999, Scandinavian journal of medicine & science in sports.

Subacute versus delayed reconstruction of the anterior cruciate ligament in the competitive athlete

J. Karlsson, B. Eriksson, J. Kartus, 1999, Knee Surgery, Sports Traumatology, Arthroscopy.

The localization of the infrapatellar nerves in the anterior knee region with special emphasis on central third patellar tendon harvest: a dissection study on cadaver and amputated specimens.

Is bracing after anterior cruciate ligament reconstruction necessary? A 2-year follow-up of 78 consecutive patients rehabilitated with or without a brace

J. Karlsson, B. Eriksson, J. Kartus, 1997, Knee Surgery, Sports Traumatology, Arthroscopy.

Recovery of calf muscle endurance 3 months after an Achilles tendon rupture

J. Karlsson, B. Eriksson, K. Silbernagel, 2016, Scandinavian journal of medicine & science in sports.

Subtalar instability of the foot: A review and results after surgical treatment

P. Renström, J. Karlsson, B. Eriksson, 1998, Scandinavian journal of medicine & science in sports.

Surgical Predictors of Early Revision Surgery After Anterior Cruciate Ligament Reconstruction

Kristian Samuelsson, Max Petzold, Magnus Forssblad, 2014, The American journal of sports medicine.

Intraarticular morphine after arthroscopic ACL reconstruction: A double-blind placebo-controlled study of 40 patients

P. Morberg, T. Hedner, J. Karlsson, 2000, Acta orthopaedica Scandinavica.

Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

M. Prins, B. Eriksson, A. Turpie, 2013, Thrombosis and Haemostasis.

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

S. Frostick, H. Büller, B. Eriksson, 2007, Journal of thrombosis and haemostasis : JTH.

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

Bengt I Eriksson, Sylvia Haas, B. Eriksson, 2008, The Lancet.

Ligament injuries of the ankle

J. Karlsson, B. Eriksson, R. Löfvenberg, 1995 .

Ligament injuries to the ankle joint

J. Karlsson, B. Eriksson, 1993 .

Direct Thrombin Inhibition with Rec-Hirudin CGP 39393 as Prophylaxis of Thromboembolie Complications after Total Hip Replacement

B. Eriksson, P. Close, P. Kälebo, 1994, Thrombosis and Haemostasis.

Ximelagatran in Orthopaedic Surgery

B. Eriksson, 2005, Pathophysiology of Haemostasis and Thrombosis.

Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.

B. Eriksson, B. Risberg, L. Tengborn, 1991, The Journal of bone and joint surgery. American volume.

Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials.

B. Eriksson, M. Feuring, J. Caprini, 2012, Thrombosis research.

Determinants of self-efficacy in the rehabilitation of patients with anterior cruciate ligament injury.

J. Karlsson, P. Thomeé, P. Währborg, 2007, Journal of rehabilitation medicine.

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)

B. Eriksson, S. Hantel, R. Friedman, 2011, Thrombosis and Haemostasis.

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

B. Eriksson, A. Cohen, G. Agnelli, 2003, Journal of thrombosis and haemostasis : JTH.

Variability in leg muscle power and hop performance after anterior cruciate ligament reconstruction

J. Karlsson, P. Thomeé, R. Thomeé, 2012, Knee Surgery, Sports Traumatology, Arthroscopy.

Letter to the Editor

K. Knobloch, J. Karlsson, R. Thomeé, 2007 .

Self-efficacy of knee function as a pre-operative predictor of outcome 1 year after anterior cruciate ligament reconstruction

J. Karlsson, P. Thomeé, P. Währborg, 2008, Knee Surgery, Sports Traumatology, Arthroscopy.

Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.

Bengt I Eriksson, J. Eikelboom, B. Eriksson, 2011, Annual review of medicine.

Will early reconstruction prevent abnormal kinematics after ACL injury? Two-year follow-up using dynamic radiostereometry in 14 patients operated with hamstring autografts

J. Kärrholm, J. Karlsson, B. Eriksson, 2011, Knee Surgery, Sports Traumatology, Arthroscopy.

Kinematics and Laxity of the Knee Joint after Anterior Cruciate Ligament Reconstruction

Johan Kärrholm, Leif Swärd, Jon Karlsson, 2002, The American journal of sports medicine.

Hand Contamination, Cross-Transmission, and Risk-Associated Behaviors: An Observational Study of Team Members in ORs.

K. Nilsson, J. Karlsson, B. Eriksson, 2015, AORN journal.

Hand hygiene and aseptic techniques during routine anesthetic care - observations in the operating room

K. Nilsson, J. Karlsson, B. Eriksson, 2015, Antimicrobial Resistance and Infection Control.

Improvements in the prevention of postoperative venous thromboembolism in hip fracture patients.

B. Eriksson, 2003, Orthopedics.

A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effect on Symptomatic Venous Thromboembolism, Death, and Bleeding

M. Gent, B. Eriksson, A. Turpie, 2008 .

Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.

M. Prins, B. Eriksson, A. Turpie, 2007 .

Comparison between mixed and laminar airflow systems in operating rooms and the influence of human factors: experiences from a Swedish orthopedic center.

Kerstin Nilsson, Max Petzold, Annette Erichsen Andersson, 2014, American journal of infection control.

Rivaroxaban vs Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

B. Eriksson, R. Friedman, L. Borris, 2008 .

Location of postoperative deep vein thrombosis in relation to age and survival.

B. Eriksson, D. Bergqvist, T. Mätzsch, 1997, The International journal of risk & safety in medicine.

Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.

B. Eriksson, M. Feuring, A. Clemens, 2012, Thrombosis research.

Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies.

B. Eriksson, U. Eriksson, L. Frison, 2002, Thrombosis research.

Pharmacokinetics of Melagatran and the Effect on Ex Vivo Coagulation Time in Orthopaedic Surgery Patients Receiving Subcutaneous Melagatran and Oral Ximelagatran

B. Eriksson, M. Karlsson, J. Mandema, 2003, Clinical Pharmacokinetics.

A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.

B. Eriksson, U. Eriksson, L. Frison, 2002, Thrombosis and haemostasis.

Self‐efficacy, symptoms and physical activity in patients with an anterior cruciate ligament injury: a prospective study

J. Karlsson, P. Thomeé, P. Währborg, 2006, Scandinavian journal of medicine & science in sports.

O1067 INFLUENCE OF THE DURATION OF FONDAPARINUX PROPHYLAXIS IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING HIP FRACTURE SURGERY

B. Eriksson, A. Turpie, K. Bauer, 2004 .

Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.

B. Eriksson, B. Risberg, P. Kälebo, 1993, Seminars in Thrombosis and Hemostasis.

A randomized, controlled study of a rehabilitation model to improve knee-function self-efficacy with ACL injury.

J. Karlsson, P. Thomeé, P. Währborg, 2010, Journal of sport rehabilitation.

Performance Enhancement following a Strength and Injury Prevention Program: A 26-Week Individualized and Supervised Intervention in Adolescent Female Volleyball Players

J. Karlsson, R. Thomeé, B. Eriksson, 2011 .

Oral Anticoagulants in Development

B. Eriksson, D. Quinlan, 2012, Drugs.

Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.

B. Eriksson, R. Friedman, M. Lassen, 2008, Clinical orthopaedics and related research.

Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.

B. Eriksson, R. Friedman, M. Lassen, 2008, Clinical orthopaedics and related research.

PROPHYLAXIS AND TREATMENT OF THROMBOEMBOLISM III NEW ORAL ANTICOAGULANTS. RESULTS OF PIVOTAL TRIALS IN ORTHOPEDIC SURGERY THE RIVAROXABAN PROGRAM

B. Eriksson, 2008 .

Full symptomatic recovery does not ensure full recovery of muscle-tendon function in patients with Achilles tendinopathy

J. Karlsson, R. Thomeé, B. Eriksson, 2007, British Journal of Sports Medicine.

Thromboembolism after total hip replacement : relationship to the fibrinolytic system

B. Eriksson, 1991 .

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.

C. Howie, M. Gent, P. Gaston, 2010, The Journal of bone and joint surgery. British volume.

Nucleostemin- and Oct 3/4-positive stem/progenitor cells exhibit disparate anatomical and temporal expression during rat Achilles tendon healing

Paul Ackermann, Bengt I Eriksson, J. Karlsson, 2015, BMC Musculoskeletal Disorders.

Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery [corrected].

B. Eriksson, A. Clemens, N. Rosencher, 2012, International orthopaedics.

The application of evidence-based measures to reduce surgical site infections during orthopedic surgery - report of a single-center experience in Sweden

K. Nilsson, J. Karlsson, B. Eriksson, 2012, Patient Safety in Surgery.

Postoperative analgesic effects of intra-articular bupivacaine and morphine after arthroscopic cruciate ligament surgery

T. Hedner, J. Karlsson, B. Eriksson, 2005, Knee Surgery, Sports Traumatology, Arthroscopy.

Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry

J. Kärrholm, B. Eriksson, O. Rolfson, 2019, Clinical orthopaedics and related research.

Acute Achilles Tendon Rupture

J. Karlsson, R. Thomeé, B. Eriksson, 2010, The American journal of sports medicine.

Extended Thromboprophylaxis with Rivaroxaban Compared with Short-Term Thromboprophylaxis with Enoxaparin after Total Hip Arthroplasty: The RECORD2 Trial.

B. Eriksson, A. Kakkar, B. Brenner, 2007 .

Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis after Total Hip Arthroplasty: The RECORD1 Trial.

B. Eriksson, W. Geerts, M. Huisman, 2007 .

Prevention of Venous Thromboembolism Following Orthopaedic Surgery

B. Eriksson, O. Dahl, 2012, Drugs.

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials

B. Eriksson, M. Feuring, A. Clemens, 2012, Thrombosis Journal.

The Achilles Tendon Total Rupture Score (ATRS)

J. Karlsson, P. Thomeé, R. Thomeé, 2007, The American journal of sports medicine.

Letter to the Editor

B. Eriksson, R. Friedman, M. Lassen, 2008, Clinical Orthopaedics and Related Research.

A New Oral Aniticoagulant, Dabigatran Etexilate, Is Effective and Safe in Preventing Venous Thromboembolism after Total Knee Replacement Surgery (The RE-MODEL Trial).

S. Frostick, H. Büller, B. Eriksson, 2006 .

Dabigatran Etexilate: Pivotal Trials for Venous Thromboembolism Prophylaxis After Hip or Knee Arthroplasty

B. Eriksson, R. Friedman, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.

C. Howie, M. Gent, P. Gaston, 2010, The Journal of bone and joint surgery. British volume.